Kinetics of Respiratory Syncytial Virus (RSV) Memphis Strain 37 (M37) Infection in the Respiratory Tract of Newborn Lambs as an RSV Infection Model for Human Infants

Kinetics of Respiratory Syncytial Virus (RSV) Memphis Strain 37 (M37) Infection in the Respiratory Tract of Newborn Lambs as an RSV Infection Model for Human Infants

Bibliographic Details
Main Authors:	Larios Mora, Alejandro, Detalle, Laurent, Van Geelen, Albert, Davis, Michael S., Stohr, Thomas, Gallup, Jack M., Ackermann, Mark R.
Format:	Online
Language:	English
Published:	Public Library of Science 2015
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4671688/

Similar Items

Human Respiratory Syncytial Virus Memphis 37 Causes Acute Respiratory Disease in Perinatal Lamb Lung
by: Derscheid, Rachel J., et al.
Published: (2014)

Human Respiratory Syncytial Virus Memphis 37 Causes Acute Respiratory Disease in Perinatal Lamb Lung
by: Rachel J. Derscheid, et al.
Published: (2014-04-01)

Perinatal Lamb Model of Respiratory Syncytial Virus (RSV) Infection
by: Derscheid, Rachel J., et al.
Published: (2012)

Effects of Formalin-Inactivated Respiratory Syncytial Virus (FI-RSV) in the Perinatal Lamb Model of RSV
by: Derscheid, Rachel J., et al.
Published: (2013)

Sucrose stabilization of Respiratory Syncytial Virus (RSV) during nebulization and experimental infection
by: Grosz, Drew D, et al.
Published: (2014)

Human Respiratory Syncytial Virus Memphis 37 Grown in HEp-2 Cells Causes more Severe Disease in Lambs than Virus Grown in Vero Cells
by: Derscheid, Rachel J., et al.
Published: (2013)

Respiratory Syncytial Virus Human Experimental Infection Model: Provenance, Production, and Sequence of Low-Passaged Memphis-37 Challenge Virus
by: Kim, Young-In, et al.
Published: (2014)

Epidemiological Changes of Respiratory Syncytial Virus (RSV) Infections in Israel
by: Hirsh, Shira, et al.
Published: (2014)

Predictors of disease severity are similar for respiratory syncytial virus (RSV)-positive and RSV-negative induced respiratory failure
by: Davis, E, et al.
Published: (2004)

Progressive Changes in Inflammatory and Matrix Adherence of Bronchial Epithelial Cells with Persistent Respiratory Syncytial Virus (RSV) Infection (Progressive Changes in RSV Infection)
by: Liu, Xiaoai, et al.
Published: (2013)

Review of palivizumab in the prophylaxis of respiratory syncytial virus (RSV) in high-risk infants
by: Mejías, Asunción, et al.
Published: (2008)

Defining the timing of respiratory syncytial virus (RSV) outbreaks: an epidemiological study
by: Terletskaia-Ladwig, Elena, et al.
Published: (2005)

Strategic priorities for respiratory syncytial virus (RSV) vaccine development
by: Anderson, L.J., et al.
Published: (2013)

Revised recommendations concerning palivizumab prophylaxis for respiratory syncytial virus (RSV)
by: Bollani, Lina, et al.
Published: (2015)

An evaluation of the emerging interventions against Respiratory Syncytial Virus (RSV)-associated acute lower respiratory infections in children
by: Nair, Harish, et al.
Published: (2011)

Influence of age, severity of infection, and co-infection on the duration of respiratory syncytial virus (RSV) shedding
by: MUNYWOKI, P. K., et al.
Published: (2015)

Respiratory syncytial virus infection in children with congenital heart disease: global data and interim results of Korean RSV-CHD survey
by: Jung, Jo Won
Published: (2011)

Respiratory syncytial virus infection in Fischer 344 rats is attenuated by short interfering RNA against the RSV-NS1 gene
by: Kong, Xiaoyuan, et al.
Published: (2007)

Respiratory Syncytial Virus (RSV) Infection in Elderly Mice Results in Altered Antiviral Gene Expression and Enhanced Pathology
by: Wong, Terianne M., et al.
Published: (2014)

Respiratory syncytial virus (RSV) entry is inhibited by serine protease inhibitor AEBSF when present during an early stage of infection
by: Winke Van der Gucht, et al.
Published: (2017-08-01)

Olfactomedin 4 Serves as a Marker for Disease Severity in Pediatric Respiratory Syncytial Virus (RSV) Infection
by: Brand, H. K., et al.
Published: (2015)

Motavizumab, A Neutralizing Anti-Respiratory Syncytial Virus (Rsv) Monoclonal Antibody Significantly Modifies The Local And Systemic Cytokine Responses Induced By Rsv In The Mouse Model
by: Mejías, Asunción, et al.
Published: (2007)

Decrease in Formalin-Inactivated Respiratory Syncytial Virus (FI-RSV) Enhanced Disease with RSV G Glycoprotein Peptide Immunization in BALB/c Mice
by: Rey, Gertrud U., et al.
Published: (2013)

Combination Therapy Using Monoclonal Antibodies against Respiratory Syncytial Virus (RSV) G Glycoprotein Protects from RSV Disease in BALB/c Mice
by: Caidi, Hayat, et al.
Published: (2012)

Respiratory Syncytial Virus Induced Type I IFN Production by pDC Is Regulated by RSV-Infected Airway Epithelial Cells, RSV-Exposed Monocytes and Virus Specific Antibodies
by: Schijf, Marcel A., et al.
Published: (2013)

Respiratory syncytial virus infection is associated with an altered innate immunity and a heightened pro-inflammatory response in the lungs of preterm lambs
by: Sow, Fatoumata B, et al.
Published: (2011)

Safety and immunogenicity of novel respiratory syncytial virus (RSV) vaccines based on the RSV viral proteins F, N and M2-1 encoded by simian adenovirus (PanAd3-RSV) and MVA (MVA-RSV); protocol for an open-label, dose-escalation, single-centre, phase 1 clinical trial in healthy adults
by: Green, C A, et al.
Published: (2015)

Palivizumab: a review of its use in the protection of high risk infants against respiratory syncytial virus (RSV)
by: Geskey, Joseph M, et al.
Published: (2007)

Introduction. RSV and RAD: possibilities for prevention? The link between respiratory syncytial virus and reactive airway disease
by: Carbonell-Estrany, Xavier, et al.
Published: (2002)

A Classification Study of Respiratory Syncytial Virus (RSV) Inhibitors by Variable Selection with Random Forest
by: Hao, Ming, et al.
Published: (2011)

The Oncolytic Effect of Respiratory Syncytial Virus (RSV) in Human Skin Cancer Cell Line, A431
by: Salimi, Vahid, et al.
Published: (2013)

A cost-effectiveness analysis of respiratory syncytial virus (RSV) prophylaxis in infants in the United Kingdom
by: Bentley, Anthony, et al.
Published: (2013)

Respiratory syncytial virus (RSV) suppression of glucocorticoid receptor phosphorylation does not account for repression of transactivation☆
by: Webster Marketon, Jeanette I., et al.
Published: (2013)

Latitudinal Variations in Seasonal Activity of Influenza and Respiratory Syncytial Virus (RSV): A Global Comparative Review
by: Bloom-Feshbach, Kimberly, et al.
Published: (2013)

A comparative study of respiratory syncytial virus (RSV) prophylaxis in premature infants within the Canadian Registry of Palivizumab (CARESS)
by: Paes, B., et al.
Published: (2012)

Respiratory Syncytial Virus (RSV) Modulation at the Virus-Host Interface Affects Immune Outcome and Disease Pathogenesis
by: Tripp, Ralph A.
Published: (2013)

Using linked routinely collected health data to explore the burden of respiratory syncytial virus (RSV) in Scotland
by: Rachel Reeves, et al.
Published: (2018-09-01)

Evolution of Human Respiratory Syncytial Virus (RSV) over Multiple Seasons in New South Wales, Australia
by: Francesca Di Giallonardo, et al.
Published: (2018-09-01)

Immunogenicity and safety of a respiratory syncytial virus fusion protein (RSV F) nanoparticle vaccine in older adults
by: Louis Fries, et al.
Published: (2017-04-01)

Global respiratory syncytial virus-associated mortality in young children (RSV GOLD): a retrospective case series
by: Nienke M Scheltema, MD, et al.
Published: (2017-10-01)